Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720
- PMID: 17948610
- DOI: 10.3816/CLC.2007.n.039
Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources